Similar to the popular social activity in which players are locked into a location and compete to solve challenges to escape, this educational version simulates a clinical eye care practice and includes three virtual rooms with challenges related to diagnosis and care for patients with retinal disease.
Vision Quest: Conquer the Challenges of Diabetic Eye Disease and nAMD
Media formats available:
Details
Presenters
Comments
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.The following faculty/staff members have the following financial relationships with ineligible companies.
Priya Vakharia, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alimera Sciences, Apellis Pharmaceuticals, Bausch + Lomb, Bayer, Coherus Biosciences, EyePoint Pharmaceuticals, Genentech, Iveric Bio, Notal Vision, Novartis, Ocuphire Pharma, and Regeneron. Grant/Research Support: 4DMT, Alexion, Annexon, Aviceda, Bayer, EyePoint Pharmaceuticals, Genentech, Ionis Pharmaceuticals, Iveric Bio, Janssen, Kodiak Sciences, Novartis, Ocular Therapeutix, ONL Therapeutics, Opthea, Regeneron, RegenxBio, and Unity Biotechnology. Shareholder: Quad-C Management/PRISM Vision. Speaker's Bureau: Apellis Pharmaceuticals, Bausch + Lomb, Bayer, Genentech, Heidelberg, Iveric Bio, Novartis, and Regeneron.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Identify key risk factors and biomarkers that aid early detection and diagnosis of DR/DME and nAMD
- Analyze factors that prevent translation of DR/DME and nAMD clinical trial treatment efficacy into real-world treatment effectiveness
- Evaluate how advances in DR/DME and nAMD treatment could improve real-world patient outcomes
- Debate the clinical significance of different measures of DR/DME and nAMD treatment efficacy and their real-world utility
- Discuss key considerations that may influence the selection, timing, and execution of DR/DME and nAMD treatment plans
- Devise effective referral strategies and plans for comanagement of DR/DME and nAMD with eye care and non-eye care specialists
Target Audience
This certified continuing education activity is designed for comprehensive ophthalmologists and retina specialists involved in the management of patients with retinal vascular diseases.
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Provider(s)/Educational Partner(s)
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.
Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron.This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Fatemeh Rajaii, MD, PhD
Prem S. Subramanian, MD, PhD
Prem S. Subramanian, MD, PhD
Fatemeh Rajaii, MD, PhD
Terry J. Smith, MD
Selina McGee, OD, FAAO
Prem S. Subramanian, MD, PhD
Terry J. Smith, MD
